1 |
Sasaki K, Takahashi S, Ouchi K, Otsuki Y, Wakayama S, Ishioka C. Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types. Sci Rep 2023;13:4868. [PMID: 36964217 DOI: 10.1038/s41598-023-32092-8] [Reference Citation Analysis]
|
2 |
Sasaki K, Takahashi S, Ouchi K, Otsuki Y, Wakayama S, Ishioka C. Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types.. [DOI: 10.21203/rs.3.rs-2385259/v1] [Reference Citation Analysis]
|
3 |
Cao J, Tu D, Zhou J, Jiang G, Jin S, Su B, Tang H, Tang Y, Wang A, Wang Q, Liu R, Zhang C, Bai D. Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC. Front Immunol 2022;13:997265. [DOI: 10.3389/fimmu.2022.997265] [Reference Citation Analysis]
|
4 |
Oshi M, Gandhi S, Yan L, Tokumaru Y, Wu R, Yamada A, Matsuyama R, Endo I, Takabe K. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast Cancer Res Treat 2022;194:231-41. [PMID: 35639264 DOI: 10.1007/s10549-022-06633-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
5 |
Wang T, Chen L, Xie F, Lin S, Lin Y, Chen J, Liu H, Wu Y. Construction and Validation of a UPR-Associated Gene Prognostic Model for Head and Neck Squamous Cell Carcinoma. Biomed Res Int 2022;2022:8677309. [PMID: 35707371 DOI: 10.1155/2022/8677309] [Reference Citation Analysis]
|
6 |
Chen X, Zha Z, Wang Y, Chen Y, Pang M, Huang L, Chen Y. Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer. J Ovarian Res 2022;15:69. [PMID: 35668504 DOI: 10.1186/s13048-022-00996-0] [Reference Citation Analysis]
|